XML 26 R79.htm IDEA: XBRL DOCUMENT v2.4.0.6
Discontinued Operations The summary of the assets and liabilities related to Pharmaceutical Manufacturing- China discontinued operations (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Nov. 13, 2012
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Noncontrolling interests $ (356,970) $ 18,106,961  
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents 0 8,810,272  
Cash and cash equivalents 13,737,452 3,935,160  
Total assets 23,800,300.0    
Pharmaceutical Manufacturing - China business [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Available-for-sale Securities, Fair Value Disclosure 13,397,900.0    
Noncontrolling interests 6,015,000.0    
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax 4,387,400.0    
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents 8,457,500.0 8,707,000  
Cash and cash equivalents     12,300,000
Restricted cash 2,918,100.0    
Accounts receivable, net 6,130,200.0 5,525,700  
Inventory 15,077,700.0 16,505,700  
Deferred income taxes   463,700  
Prepaid expenses and other current assets 957,800.0 777,500  
Property, plant and equipment, net 38,102,000.0 36,490,400  
Land use rights, net   4,872,400  
Goodwill   8,495,700  
Intangible assets, net   21,846,400  
Other assets 5,946,300.0 2,459,900  
Total assets   106,144,400  
Accounts Payable (9,604,800.0) (7,950,300)  
Accrued liabilities (2,008,800.0) (1,705,800)  
Bank loans (15,133,500.0) (15,712,000)  
Notes payable (6,599,300.0)    
Income tax payable   621,600  
Deferred income taxes   6,177,400  
Unearned revenue (9,166,800.0) (1,315,400)  
Amount due related parties (7,859,700.0) (20,862,700)  
Total Liabilities 27,216,700.0 54,345,200  
Loss on exit of segment $ (3,416,400.0) $ 0  
Treasury Stock, Shares     1,040,000
Stock Option Cancelled     1,170,000
Warrants Cancelled     640,000